data_1ssk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ssk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtm . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.89 0.376 . . . . 12.07 111.263 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.51 -82.88 1.65 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 10.21 112.325 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.71 150.99 30.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 10.52 110.855 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.9 p 49.54 94.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 9.66 111.025 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.19 125.15 49.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 9.58 110.833 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -81.28 164.28 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 10.81 110.856 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -55.68 -176.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 9.74 110.717 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -67.77 73.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 10.1 110.902 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -122.29 79.47 1.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.278 -0.419 . . . . 10.92 110.932 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -31.64 71.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 10.15 110.776 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m 73.72 40.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 10.4 111.019 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 m -117.09 -39.29 3.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.312 -0.403 . . . . 10.24 110.919 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.82 93.93 0.75 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.784 -0.722 . . . . 9.92 112.351 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.18 -42.05 72.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.788 0.328 . . . . 10.55 110.94 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -50.78 136.45 26.19 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 8.41 110.925 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.0 -60.67 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.287 1.992 . . . . 8.62 112.54 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.96 105.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 11.32 110.91 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.92 36.96 3.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.741 . . . . 7.46 112.607 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.2 m 50.67 29.16 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.661 0.267 . . . . 9.31 111.162 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 48.18 69.32 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.408 -0.36 . . . . 7.61 111.022 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -81.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 8.38 111.184 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.91 22.1 18.62 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.783 -0.722 . . . . 5.96 112.833 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mt -145.82 161.45 40.2 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.682 0.277 . . . . 7.2 110.33 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -51.32 111.97 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.369 2.046 . . . . 5.29 111.517 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -43.08 -65.63 0.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.511 -0.768 . . . . 5.99 111.526 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -142.32 36.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.351 -0.386 . . . . 4.09 110.954 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.97 110.58 10.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 2.01 111.256 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.62 -54.91 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 1.6 111.113 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 168.45 86.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 2.16 110.732 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 30' ' ' TRP . 53.8 t-105 -78.76 60.16 2.72 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.058 0.456 . . . . 1.37 110.482 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 137' ' ' LEU . 0.1 OUTLIER 168.58 -179.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.968 -0.56 . . . . 1.58 109.973 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.407 ' CG2' ' CG1' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -107.37 -172.02 1.99 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.419 0.628 . . . . 1.09 112.03 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.412 ' HB1' ' CD1' ' A' ' 87' ' ' TYR . . . -140.1 132.65 28.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.23 -0.895 . . . . 1.06 111.074 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.427 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 1.7 tp -73.13 113.04 9.74 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.523 -0.547 . . . . 1.18 109.523 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.86 115.99 21.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 1.55 111.265 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.424 ' HB2' ' CD2' ' A' ' 149' ' ' PHE . 5.0 tm0? -97.73 116.75 30.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 2.25 110.967 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -109.63 -20.48 12.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 2.01 111.332 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.37 -156.58 0.04 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.747 -0.739 . . . . 2.21 112.56 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -110.58 25.29 11.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.485 0.183 . . . . 4.61 111.452 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -130.82 -168.96 2.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.785 0.326 . . . . 2.52 110.839 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -116.81 165.64 13.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 2.13 110.721 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.442 HD21 ' CD1' ' A' ' 65' ' ' TYR . 8.3 tt -59.78 144.35 48.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 1.12 111.231 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.74 76.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.676 -0.693 . . . . 2.8 109.939 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.473 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 88.5 m-85 -46.02 138.54 5.8 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.57 -0.741 . . . . 1.91 111.196 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -52.4 173.4 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.682 2.254 . . . . 0.62 112.52 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -177.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.535 . . . . 5.94 110.879 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.45 -61.02 0.89 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 1.97 112.338 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -136.09 -56.28 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.392 . . . . 2.84 110.779 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.12 -48.98 3.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.874 -0.679 . . . . 1.0 112.467 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.99 140.81 21.5 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.08 -0.341 . . . . 1.03 110.08 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HB3' ' HB2' ' A' ' 137' ' ' LEU . 5.3 Cg_endo -48.64 177.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.686 2.257 . . . . 1.13 113.09 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.424 HD13 HG23 ' A' ' 52' ' ' ILE . 4.3 mt -65.26 -30.4 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.426 -0.806 . . . . 1.34 111.236 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.08 179.13 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 2.86 111.061 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.67 -64.92 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 1.38 111.063 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -152.92 33.83 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 2.55 110.742 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.416 ' HB3' ' CG ' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -97.76 36.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 1.9 111.003 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.53 90.89 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.678 -0.772 . . . . 1.37 112.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -55.88 -62.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.639 2.226 . . . . 1.66 112.064 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -121.33 31.65 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.03 -0.532 . . . . 2.02 110.617 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -150.55 54.14 0.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 2.1 110.881 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -70.72 66.37 0.35 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 1.84 110.811 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.423 HD12 ' CE1' ' A' ' 101' ' ' TYR . 28.9 pt -113.69 177.79 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 1.06 110.22 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.87 -158.99 27.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 119.709 -1.234 . . . . 0.28 113.479 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.495 ' CE2' ' CD2' ' A' ' 89' ' ' TYR . 19.1 p90 -165.14 176.21 8.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.655 0.264 . . . . 2.15 110.724 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.473 ' CZ ' ' CE1' ' A' ' 44' ' ' PHE . 6.8 m-85 -123.05 134.56 54.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 2.12 110.877 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.84 111.67 24.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 3.17 110.725 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -52.34 106.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 3.0 111.043 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.34 126.87 42.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.022 -0.535 . . . . 1.19 110.964 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.8 p -119.46 103.34 9.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 1.37 111.015 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.61 148.42 25.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 4.04 111.008 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.6 137.79 53.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 4.15 110.818 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.63 133.47 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 3.15 111.32 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.28 85.64 7.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 6.21 110.676 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.82 158.78 53.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.833 -0.699 . . . . 5.18 112.639 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 47.97 -155.03 1.31 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 6.73 112.631 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.75 74.88 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 8.9 110.922 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.3 34.25 5.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 5.87 112.506 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -110.16 163.58 13.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.815 0.341 . . . . 7.87 110.98 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.85 105.7 9.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 5.04 110.827 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -31.19 23.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.005 -0.543 . . . . 4.27 110.816 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 63.44 94.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 3.56 110.587 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 tp -46.85 141.39 4.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 3.26 111.173 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.5 m -56.18 114.35 7.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.988 -0.551 . . . . 1.89 111.055 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.58 142.51 9.75 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.293 1.995 . . . . 1.3 112.214 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -163.14 152.1 14.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.435 -0.348 . . . . 2.26 111.166 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 1.7 m95 -106.12 125.99 51.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.37 109.967 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.412 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 36.2 m-85 -85.94 138.8 31.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.114 -0.235 . . . . 1.78 110.641 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.61 144.44 54.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.193 0.52 . . . . 0.24 111.766 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.495 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 83.1 t80 -132.65 88.61 2.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.469 -0.787 . . . . 1.62 109.983 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.416 ' CG ' ' HB3' ' A' ' 56' ' ' SER . 9.5 p90 -53.22 158.13 1.69 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.97 0.414 . . . . 2.43 110.888 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.435 ' CD2' ' CE2' ' A' ' 89' ' ' TYR . 21.6 mt -160.05 146.38 15.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.878 -0.601 . . . . 1.14 110.982 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.91 -94.11 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.647 -0.706 . . . . 1.6 112.287 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 p -149.07 -54.09 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.682 0.277 . . . . 1.31 111.383 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -49.35 -57.94 8.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.497 -0.859 . . . . 0.82 112.374 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -60.98 -149.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.865 2.376 . . . . 1.71 111.703 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.89 -64.63 0.66 Allowed 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.687 0.28 . . . . 2.45 110.943 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 47.08 29.02 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 1.3 111.254 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 t -98.12 -39.82 8.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 1.79 110.949 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 mp -47.6 166.41 0.2 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 1.72 110.626 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.63 3.49 5.89 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.661 2.241 . . . . 0.97 113.682 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.423 ' CE1' HD12 ' A' ' 62' ' ' ILE . 17.5 t80 61.61 74.25 0.45 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.029 0.443 . . . . 1.83 110.551 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA2' ' CD2' ' A' ' 110' ' ' TRP . . . 116.28 25.64 3.44 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.82 -0.627 . . . . 0.59 112.607 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.66 80.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.399 . . . . 1.45 111.059 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -48.39 138.76 9.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 2.45 110.936 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.54 -173.16 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 2.87 110.932 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -78.28 -64.51 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 2.66 110.891 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.45 27.97 15.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.96 112.524 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.426 HG21 ' CD1' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -127.47 131.27 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 1.21 111.065 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.9 109.42 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 1.1 111.135 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.411 ' CD2' ' HA2' ' A' ' 102' ' ' GLY . 57.5 m95 -84.99 151.52 24.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.011 -0.54 . . . . 0.51 111.547 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -163.88 132.71 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.619 -0.719 . . . . 1.01 110.752 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.31 147.19 46.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 1.1 111.353 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.3 t -61.34 170.63 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.525 . . . . 1.14 111.04 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -68.4 70.76 0.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 2.7 111.01 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.29 82.68 1.43 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 1.54 112.614 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.52 125.7 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.789 0.328 . . . . 1.28 110.862 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.2 tp -89.44 -21.16 23.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 1.73 111.957 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 75.18 108.14 0.07 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.799 0.333 . . . . 2.57 110.895 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.7 p -145.69 158.35 49.96 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 1.53 111.279 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.55 135.02 11.44 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.917 2.412 . . . . 1.04 112.768 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.86 83.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 4.75 110.712 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.46 126.53 50.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 3.12 110.92 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.411 ' CD2' HD12 ' A' ' 124' ' ' ILE . 1.2 p-80 170.38 42.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.221 -0.445 . . . . 1.68 110.908 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.411 HD12 ' CD2' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -147.51 -177.04 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 1.51 111.216 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 68.01 33.57 79.49 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.775 -0.726 . . . . 1.75 111.925 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.79 77.95 1.57 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.859 0.361 . . . . 1.45 110.913 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -81.51 58.4 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 2.19 111.394 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 130' ' ' ASN . 11.7 t30 -59.59 127.1 84.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.557 -0.535 . . . . 2.76 109.557 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.08 78.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.489 2.126 . . . . 1.54 112.521 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 128' ' ' ASN . 1.9 m-20 167.45 -34.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.881 -0.6 . . . . 3.42 110.258 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.79 -70.32 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.96 -0.564 . . . . 3.18 110.882 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -175.2 160.77 2.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.277 -0.419 . . . . 3.07 111.318 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.405 ' O ' ' CZ3' ' A' ' 30' ' ' TRP . . . -61.48 -163.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.553 . . . . 2.01 110.818 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -102.66 129.47 49.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 1.42 111.422 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 m -55.45 -23.16 23.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 1.23 111.986 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.407 ' CG1' ' CG2' ' A' ' 32' ' ' THR . 3.6 m 47.81 114.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.675 0.79 . . . . 1.1 112.934 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.457 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -43.18 167.67 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.354 -0.839 . . . . 1.2 112.567 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -158.11 86.27 0.89 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.226 -0.897 . . . . 2.14 110.352 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' A' ' 44' ' ' PHE . 96.3 mt -45.54 138.95 4.92 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.223 -0.444 . . . . 1.08 111.206 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.39 -162.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.332 2.021 . . . . 1.05 112.052 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -51.01 -53.84 29.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.974 0.416 . . . . 2.85 110.18 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.23 -123.09 2.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.866 -0.683 . . . . 1.84 111.693 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 m 48.16 40.77 14.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.969 0.414 . . . . 1.09 110.859 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -164.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.829 -0.623 . . . . 2.01 111.462 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.15 154.89 42.58 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.324 . . . . 1.31 110.843 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.429 ' HB2' ' CE1' ' A' ' 149' ' ' PHE . 36.6 Cg_exo -59.0 -147.88 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.938 2.425 . . . . 0.62 112.551 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -46.16 -86.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.504 0.187 . . . . 3.09 111.504 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -121.68 78.43 0.33 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.687 -0.768 . . . . 1.9 111.932 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.429 ' CE1' ' HB2' ' A' ' 146' ' ' PRO . 4.9 m-85 -117.17 154.82 30.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.881 0.372 . . . . 1.9 111.405 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.407 ' CZ ' ' HA2' ' A' ' 153' ' ' GLY . 4.5 t80 -115.41 126.46 54.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.571 . . . . 2.33 110.574 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.4 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -45.03 165.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.867 -0.606 . . . . 0.99 112.226 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.75 -36.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.0 -1.0 . . . . 2.03 112.056 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.407 ' HA2' ' CZ ' ' A' ' 150' ' ' TYR . . . 127.83 -65.2 0.58 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.446 -0.883 . . . . 1.62 112.449 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 76.3 p 50.38 77.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.356 . . . . 2.31 110.933 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 110.52 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 7.18 110.861 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.62 90.43 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 5.02 112.51 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 120.74 105.23 2.0 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.726 -0.749 . . . . 7.45 112.481 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.208 -0.901 . . . . 9.85 110.901 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtm . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.89 0.376 . . . . 11.789999999999999 111.263 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.51 -82.88 1.65 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 9.9700000000000006 112.325 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.71 150.99 30.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 10.24 110.855 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.9 p 49.54 94.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 9.4199999999999999 111.025 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.19 125.15 49.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 9.0999999999999996 110.833 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -81.28 164.28 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 10.15 110.856 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -55.68 -176.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 9.1500000000000004 110.717 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -67.77 73.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 9.5800000000000001 110.902 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -122.29 79.47 1.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.278 -0.419 . . . . 10.279999999999999 110.932 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -31.64 71.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 9.5199999999999996 110.776 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m 73.72 40.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 10.140000000000001 111.019 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 m -117.09 -39.29 3.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.312 -0.403 . . . . 10.029999999999999 110.919 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.82 93.93 0.75 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.784 -0.722 . . . . 9.5199999999999996 112.351 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -55.18 -42.05 72.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.788 0.328 . . . . 10.31 110.94 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.616 ' N ' HD23 ' A' ' 14' ' ' LEU . 14.5 p -50.78 136.45 26.19 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 8.1099999999999994 110.925 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.0 -60.67 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.287 1.992 . . . . 8.0800000000000001 112.54 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.96 105.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 10.710000000000001 110.91 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.92 36.96 3.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.741 . . . . 7.46 112.607 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.2 m 50.67 29.16 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.661 0.267 . . . . 8.8900000000000006 111.162 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 48.18 69.32 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.408 -0.36 . . . . 7.3399999999999999 111.022 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -81.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 8.1400000000000006 111.184 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.91 22.1 18.62 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.783 -0.722 . . . . 5.6699999999999999 112.833 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mt -145.82 161.45 40.2 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.682 0.277 . . . . 6.8499999999999996 110.33 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HB3' HG23 ' A' ' 27' ' ' THR . 75.6 Cg_exo -51.32 111.97 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.369 2.046 . . . . 4.8300000000000001 111.517 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -43.08 -65.63 0.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.511 -0.768 . . . . 5.4299999999999997 111.526 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -142.32 36.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.351 -0.386 . . . . 3.4500000000000002 110.954 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.403 HG23 ' HB3' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -132.97 110.58 10.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 1.49 111.256 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.62 -54.91 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 1.6000000000000001 111.113 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 168.45 86.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 1.6499999999999999 110.732 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 30' ' ' TRP . 53.8 t-105 -78.76 60.16 2.72 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.058 0.456 . . . . 1.3700000000000001 110.482 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.737 ' N ' ' HB1' ' A' ' 134' ' ' ALA . 0.1 OUTLIER 168.58 -179.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.968 -0.56 . . . . 0.93000000000000005 109.973 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.801 HG23 HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -107.37 -172.02 1.99 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.419 0.628 . . . . 0.28000000000000003 112.03 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB2' ' CD1' ' A' ' 87' ' ' TYR . . . -140.1 132.65 28.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.23 -0.895 . . . . 0.23999999999999999 111.074 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.437 HD13 ' CZ ' ' A' ' 44' ' ' PHE . 1.7 tp -73.13 113.04 9.74 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.523 -0.547 . . . . 0.47999999999999998 109.523 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.86 115.99 21.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.82999999999999996 111.265 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.418 ' HB2' ' CD2' ' A' ' 149' ' ' PHE . 5.0 tm0? -97.73 116.75 30.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 1.79 110.967 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -109.63 -20.48 12.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 1.49 111.332 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.37 -156.58 0.04 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.747 -0.739 . . . . 1.6200000000000001 112.56 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -110.58 25.29 11.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.485 0.183 . . . . 4.1699999999999999 111.452 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -130.82 -168.96 2.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.785 0.326 . . . . 2.52 110.839 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -116.81 165.64 13.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 2.1299999999999999 110.721 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.768 HD23 ' N ' ' A' ' 43' ' ' ARG . 8.3 tt -59.78 144.35 48.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 0.33000000000000002 111.231 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.768 ' N ' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 171.74 76.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.676 -0.693 . . . . 2.3199999999999998 109.939 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.668 ' HE2' HD11 ' A' ' 139' ' ' LEU . 88.5 m-85 -46.02 138.54 5.8 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.57 -0.741 . . . . 1.1000000000000001 111.196 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -52.4 173.4 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.682 2.254 . . . . 0.60999999999999999 112.52 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -177.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.535 . . . . 5.4299999999999997 110.879 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.45 -61.02 0.89 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 1.97 112.338 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -136.09 -56.28 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.392 . . . . 2.5 110.779 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.12 -48.98 3.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.874 -0.679 . . . . 0.70999999999999996 112.467 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.99 140.81 21.5 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.08 -0.341 . . . . 0.22 110.08 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HB3' ' HB2' ' A' ' 137' ' ' LEU . 5.3 Cg_endo -48.64 177.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.686 2.257 . . . . 0.68999999999999995 113.09 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.498 HG22 ' O ' ' A' ' 53' ' ' ASN . 4.3 mt -65.26 -30.4 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.426 -0.806 . . . . 0.68999999999999995 111.236 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.498 ' O ' HG22 ' A' ' 52' ' ' ILE . 2.8 m-20 63.08 179.13 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 2.3100000000000001 111.061 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.67 -64.92 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 1.29 111.063 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -152.92 33.83 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 2.54 110.742 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.438 ' HB3' ' CG ' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -97.76 36.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 1.79 111.003 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.53 90.89 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.678 -0.772 . . . . 0.91000000000000003 112.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -55.88 -62.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.639 2.226 . . . . 1.6599999999999999 112.064 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -121.33 31.65 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.03 -0.532 . . . . 2.02 110.617 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -150.55 54.14 0.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 2.1000000000000001 110.881 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -70.72 66.37 0.35 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 1.4299999999999999 110.811 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.504 HD12 ' CD1' ' A' ' 101' ' ' TYR . 28.9 pt -113.69 177.79 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.34000000000000002 110.22 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 91' ' ' LEU . . . 146.87 -158.99 27.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 119.709 -1.234 . . . . 0.27000000000000002 113.479 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.495 ' CE2' ' CD2' ' A' ' 89' ' ' TYR . 19.1 p90 -165.14 176.21 8.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.655 0.264 . . . . 1.26 110.724 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.491 ' HE1' HG11 ' A' ' 111' ' ' VAL . 6.8 m-85 -123.05 134.56 54.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 1.24 110.877 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.84 111.67 24.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 2.6299999999999999 110.725 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -52.34 106.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 2.54 111.043 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.34 126.87 42.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.022 -0.535 . . . . 0.53000000000000003 110.964 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.8 p -119.46 103.34 9.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.97999999999999998 111.015 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.61 148.42 25.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 3.5800000000000001 111.008 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.6 137.79 53.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 3.7999999999999998 110.818 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.649 HG11 HD13 ' A' ' 82' ' ' LEU . 32.6 m -124.63 133.47 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 3.1499999999999999 111.32 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.28 85.64 7.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 5.7800000000000002 110.676 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.82 158.78 53.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.833 -0.699 . . . . 5.1799999999999997 112.639 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 47.97 -155.03 1.31 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 6.7300000000000004 112.631 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.75 74.88 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 8.9000000000000004 110.922 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.3 34.25 5.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 5.8700000000000001 112.506 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -110.16 163.58 13.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.815 0.341 . . . . 7.5300000000000002 110.98 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.85 105.7 9.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 4.6799999999999997 110.827 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.622 ' HE2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -85.07 -31.19 23.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.005 -0.543 . . . . 3.9700000000000002 110.816 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 63.44 94.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 3.5600000000000001 110.587 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.649 HD13 HG11 ' A' ' 72' ' ' VAL . 5.6 tp -46.85 141.39 4.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 2.73 111.173 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.5 m -56.18 114.35 7.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.988 -0.551 . . . . 1.46 111.055 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.58 142.51 9.75 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.293 1.995 . . . . 0.93999999999999995 112.214 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -163.14 152.1 14.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.435 -0.348 . . . . 1.6899999999999999 111.166 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.5 ' CZ3' HG23 ' A' ' 109' ' ' VAL . 1.7 m95 -106.12 125.99 51.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.32000000000000001 109.967 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.471 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 36.2 m-85 -85.94 138.8 31.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.114 -0.235 . . . . 1.03 110.641 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.61 144.44 54.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.193 0.52 . . . . 0.23999999999999999 111.766 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.864 ' CE2' HD21 ' A' ' 91' ' ' LEU . 83.1 t80 -132.65 88.61 2.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.469 -0.787 . . . . 0.98999999999999999 109.983 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' CG ' ' HB3' ' A' ' 56' ' ' SER . 9.5 p90 -53.22 158.13 1.69 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.97 0.414 . . . . 1.5700000000000001 110.888 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.864 HD21 ' CE2' ' A' ' 89' ' ' TYR . 21.6 mt -160.05 146.38 15.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.878 -0.601 . . . . 0.45000000000000001 110.982 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.91 -94.11 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.647 -0.706 . . . . 1.6000000000000001 112.287 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.412 ' HA ' ' CB ' ' A' ' 97' ' ' ALA . 3.1 p -149.07 -54.09 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.682 0.277 . . . . 0.71999999999999997 111.383 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -49.35 -57.94 8.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.497 -0.859 . . . . 0.79000000000000004 112.374 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -60.98 -149.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.865 2.376 . . . . 1.71 111.703 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.89 -64.63 0.66 Allowed 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.687 0.28 . . . . 2.4500000000000002 110.943 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 93' ' ' THR . . . 47.08 29.02 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.87 111.254 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 t -98.12 -39.82 8.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 1.51 110.949 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.723 HD23 ' HZ2' ' A' ' 110' ' ' TRP . 7.8 mp -47.6 166.41 0.2 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 1.1200000000000001 110.626 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.826 ' CG ' ' HB2' ' A' ' 103' ' ' ALA . 73.8 Cg_endo -75.63 3.49 5.89 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.661 2.241 . . . . 0.65000000000000002 113.682 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.504 ' CD1' HD12 ' A' ' 62' ' ' ILE . 17.5 t80 61.61 74.25 0.45 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.029 0.443 . . . . 1.0900000000000001 110.551 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 110' ' ' TRP . . . 116.28 25.64 3.44 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.82 -0.627 . . . . 0.47999999999999998 112.607 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.826 ' HB2' ' CG ' ' A' ' 100' ' ' PRO . . . -64.66 80.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.399 . . . . 1.45 111.059 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -48.39 138.76 9.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 2.1499999999999999 110.936 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.54 -173.16 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 2.3500000000000001 110.932 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -78.28 -64.51 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 2.6600000000000001 110.891 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.45 27.97 15.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.46999999999999997 112.524 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.423 HG23 ' CD1' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -127.47 131.27 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.56999999999999995 111.065 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.736 HG21 ' O ' ' A' ' 42' ' ' LEU . 47.2 t -115.9 109.42 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.40999999999999998 111.135 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.723 ' HZ2' HD23 ' A' ' 99' ' ' LEU . 57.5 m95 -84.99 151.52 24.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.011 -0.54 . . . . 0.45000000000000001 111.547 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.491 HG11 ' HE1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -163.88 132.71 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.619 -0.719 . . . . 0.20999999999999999 110.752 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB1' HG22 ' A' ' 62' ' ' ILE . . . -121.31 147.19 46.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 0.45000000000000001 111.353 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.3 t -61.34 170.63 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.525 . . . . 0.54000000000000004 111.04 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -68.4 70.76 0.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 2.7000000000000002 111.01 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.29 82.68 1.43 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 1.54 112.614 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.52 125.7 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.789 0.328 . . . . 0.76000000000000001 110.862 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.2 tp -89.44 -21.16 23.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 1.73 111.957 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 75.18 108.14 0.07 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.799 0.333 . . . . 2.5699999999999998 110.895 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.7 p -145.69 158.35 49.96 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 0.83999999999999997 111.279 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.55 135.02 11.44 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.917 2.412 . . . . 0.97999999999999998 112.768 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.86 83.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 4.2800000000000002 110.712 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.46 126.53 50.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 3.1200000000000001 110.92 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.411 ' CD2' HD13 ' A' ' 124' ' ' ILE . 1.2 p-80 170.38 42.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.221 -0.445 . . . . 1.6799999999999999 110.908 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.411 HD13 ' CD2' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -147.51 -177.04 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.92000000000000004 111.216 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 68.01 33.57 79.49 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.775 -0.726 . . . . 1.75 111.925 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.79 77.95 1.57 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.859 0.361 . . . . 1.1699999999999999 110.913 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -81.51 58.4 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 1.8899999999999999 111.394 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 130' ' ' ASN . 11.7 t30 -59.59 127.1 84.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.557 -0.535 . . . . 2.4199999999999999 109.557 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.08 78.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.489 2.126 . . . . 1.5 112.521 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 128' ' ' ASN . 1.9 m-20 167.45 -34.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.881 -0.6 . . . . 2.8399999999999999 110.258 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.79 -70.32 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.96 -0.564 . . . . 2.75 110.882 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -175.2 160.77 2.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.277 -0.419 . . . . 2.6299999999999999 111.318 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.405 ' O ' ' CZ3' ' A' ' 30' ' ' TRP . . . -61.48 -163.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.553 . . . . 2.0099999999999998 110.818 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.737 ' HB1' ' N ' ' A' ' 31' ' ' PHE . . . -102.66 129.47 49.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 1.4199999999999999 111.422 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 m -55.45 -23.16 23.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.52000000000000002 111.986 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.801 HG12 HG23 ' A' ' 32' ' ' THR . 3.6 m 47.81 114.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.675 0.79 . . . . 0.77000000000000002 112.934 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -43.18 167.67 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.354 -0.839 . . . . 0.40999999999999998 112.567 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -158.11 86.27 0.89 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.226 -0.897 . . . . 1.6599999999999999 110.352 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.82 HD13 ' O ' ' A' ' 143' ' ' THR . 96.3 mt -45.54 138.95 4.92 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.206 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 139' ' ' LEU . 35.5 Cg_exo -59.39 -162.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.332 2.021 . . . . 0.85999999999999999 112.052 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -51.01 -53.84 29.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.974 0.416 . . . . 2.3999999999999999 110.18 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.23 -123.09 2.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.866 -0.683 . . . . 1.8400000000000001 111.693 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.82 ' O ' HD13 ' A' ' 139' ' ' LEU . 2.6 m 48.16 40.77 14.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.969 0.414 . . . . 0.56000000000000005 110.859 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.622 ' C ' HD23 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -57.48 -164.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.829 -0.623 . . . . 1.53 111.462 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -110.15 154.89 42.58 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.324 . . . . 0.68999999999999995 110.843 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.449 ' HB2' ' CE1' ' A' ' 149' ' ' PHE . 36.6 Cg_exo -59.0 -147.88 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.938 2.425 . . . . 0.62 112.551 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -46.16 -86.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.504 0.187 . . . . 2.6099999999999999 111.504 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -121.68 78.43 0.33 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.687 -0.768 . . . . 1.8999999999999999 111.932 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.673 ' O ' HD12 ' A' ' 145' ' ' LEU . 4.9 m-85 -117.17 154.82 30.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.881 0.372 . . . . 1.1000000000000001 111.405 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.415 ' CZ ' ' HA2' ' A' ' 153' ' ' GLY . 4.5 t80 -115.41 126.46 54.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.571 . . . . 1.4299999999999999 110.574 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.735 ' HB1' ' OE2' ' A' ' 152' ' ' GLU . . . -45.03 165.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.867 -0.606 . . . . 0.33000000000000002 112.226 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.735 ' OE2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -35.75 -36.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.0 -1.0 . . . . 2.0299999999999998 112.056 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.415 ' HA2' ' CZ ' ' A' ' 150' ' ' TYR . . . 127.83 -65.2 0.58 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.446 -0.883 . . . . 1.5 112.449 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 76.3 p 50.38 77.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.356 . . . . 1.97 110.933 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 110.52 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 6.5499999999999998 110.861 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.62 90.43 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 5.0199999999999996 112.51 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 120.74 105.23 2.0 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.726 -0.749 . . . . 7.4500000000000002 112.481 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.208 -0.901 . . . . 9.8499999999999996 110.901 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtm . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.89 0.376 . . . . 11.79 111.263 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.51 -82.88 1.65 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 9.97 112.325 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.71 150.99 30.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 10.24 110.855 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.9 p 49.54 94.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 9.42 111.025 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.19 125.15 49.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 9.1 110.833 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -81.28 164.28 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 10.15 110.856 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -55.68 -176.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 9.15 110.717 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -67.77 73.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 9.58 110.902 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -122.29 79.47 1.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.278 -0.419 . . . . 10.28 110.932 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -31.64 71.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 9.52 110.776 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m 73.72 40.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 10.14 111.019 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 m -117.09 -39.29 3.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.312 -0.403 . . . . 10.03 110.919 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.82 93.93 0.75 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.784 -0.722 . . . . 9.52 112.351 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -55.18 -42.05 72.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.788 0.328 . . . . 10.31 110.94 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.616 ' N ' HD23 ' A' ' 14' ' ' LEU . 14.5 p -50.78 136.45 26.19 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 8.11 110.925 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.0 -60.67 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.287 1.992 . . . . 8.08 112.54 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.96 105.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 10.71 110.91 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.92 36.96 3.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.741 . . . . 7.46 112.607 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.2 m 50.67 29.16 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.661 0.267 . . . . 8.89 111.162 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 48.18 69.32 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.408 -0.36 . . . . 7.34 111.022 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -81.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 8.14 111.184 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.91 22.1 18.62 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.783 -0.722 . . . . 5.67 112.833 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mt -145.82 161.45 40.2 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.682 0.277 . . . . 6.85 110.33 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HB3' HG23 ' A' ' 27' ' ' THR . 75.6 Cg_exo -51.32 111.97 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.369 2.046 . . . . 4.83 111.517 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -43.08 -65.63 0.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.511 -0.768 . . . . 5.43 111.526 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -142.32 36.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.351 -0.386 . . . . 3.45 110.954 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.403 HG23 ' HB3' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -132.97 110.58 10.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 1.49 111.256 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.62 -54.91 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 1.6 111.113 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 168.45 86.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 1.65 110.732 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 30' ' ' TRP . 53.8 t-105 -78.76 60.16 2.72 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.058 0.456 . . . . 1.37 110.482 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.737 ' N ' ' HB1' ' A' ' 134' ' ' ALA . 0.1 OUTLIER 168.58 -179.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.968 -0.56 . . . . 0.93 109.973 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.801 HG23 HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -107.37 -172.02 1.99 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.419 0.628 . . . . 0.28 112.03 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HB2' ' CD1' ' A' ' 87' ' ' TYR . . . -140.1 132.65 28.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.23 -0.895 . . . . 0.24 111.074 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.437 HD13 ' CZ ' ' A' ' 44' ' ' PHE . 1.7 tp -73.13 113.04 9.74 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.523 -0.547 . . . . 0.48 109.523 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.86 115.99 21.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.83 111.265 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.418 ' HB2' ' CD2' ' A' ' 149' ' ' PHE . 5.0 tm0? -97.73 116.75 30.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 1.79 110.967 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -109.63 -20.48 12.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 1.49 111.332 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.37 -156.58 0.04 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.747 -0.739 . . . . 1.62 112.56 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -110.58 25.29 11.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.485 0.183 . . . . 4.17 111.452 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -130.82 -168.96 2.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.785 0.326 . . . . 2.52 110.839 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -116.81 165.64 13.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 2.13 110.721 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.768 HD23 ' N ' ' A' ' 43' ' ' ARG . 8.3 tt -59.78 144.35 48.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 0.33 111.231 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.768 ' N ' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 171.74 76.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.676 -0.693 . . . . 2.32 109.939 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.668 ' HE2' HD11 ' A' ' 139' ' ' LEU . 88.5 m-85 -46.02 138.54 5.8 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.57 -0.741 . . . . 1.1 111.196 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -52.4 173.4 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.682 2.254 . . . . 0.61 112.52 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -177.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.535 . . . . 5.43 110.879 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.45 -61.02 0.89 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 1.97 112.338 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -136.09 -56.28 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.392 . . . . 2.5 110.779 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.12 -48.98 3.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.874 -0.679 . . . . 0.71 112.467 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.99 140.81 21.5 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.08 -0.341 . . . . 0.22 110.08 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HB3' ' HB2' ' A' ' 137' ' ' LEU . 5.3 Cg_endo -48.64 177.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.686 2.257 . . . . 0.69 113.09 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.498 HG22 ' O ' ' A' ' 53' ' ' ASN . 4.3 mt -65.26 -30.4 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.426 -0.806 . . . . 0.69 111.236 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.498 ' O ' HG22 ' A' ' 52' ' ' ILE . 2.8 m-20 63.08 179.13 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 2.31 111.061 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.67 -64.92 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 1.29 111.063 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -152.92 33.83 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 2.54 110.742 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.438 ' HB3' ' CG ' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -97.76 36.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 1.79 111.003 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.53 90.89 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.678 -0.772 . . . . 0.91 112.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -55.88 -62.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.639 2.226 . . . . 1.66 112.064 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -121.33 31.65 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.03 -0.532 . . . . 2.02 110.617 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -150.55 54.14 0.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 2.1 110.881 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -70.72 66.37 0.35 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 1.43 110.811 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.504 HD12 ' CD1' ' A' ' 101' ' ' TYR . 28.9 pt -113.69 177.79 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.34 110.22 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 91' ' ' LEU . . . 146.87 -158.99 27.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 119.709 -1.234 . . . . 0.27 113.479 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.495 ' CE2' ' CD2' ' A' ' 89' ' ' TYR . 19.1 p90 -165.14 176.21 8.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.655 0.264 . . . . 1.26 110.724 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.491 ' HE1' HG11 ' A' ' 111' ' ' VAL . 6.8 m-85 -123.05 134.56 54.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 1.24 110.877 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.84 111.67 24.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 2.63 110.725 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -52.34 106.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 2.54 111.043 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.34 126.87 42.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.022 -0.535 . . . . 0.53 110.964 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.8 p -119.46 103.34 9.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.98 111.015 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.61 148.42 25.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 3.58 111.008 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.6 137.79 53.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 3.8 110.818 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.649 HG11 HD13 ' A' ' 82' ' ' LEU . 32.6 m -124.63 133.47 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 3.15 111.32 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.28 85.64 7.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 5.78 110.676 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.82 158.78 53.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.833 -0.699 . . . . 5.18 112.639 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 47.97 -155.03 1.31 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 6.73 112.631 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.75 74.88 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 8.9 110.922 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.3 34.25 5.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 5.87 112.506 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -110.16 163.58 13.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.815 0.341 . . . . 7.53 110.98 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.85 105.7 9.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 4.68 110.827 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.622 ' HE2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -85.07 -31.19 23.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.005 -0.543 . . . . 3.97 110.816 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 63.44 94.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 3.56 110.587 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.649 HD13 HG11 ' A' ' 72' ' ' VAL . 5.6 tp -46.85 141.39 4.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 2.73 111.173 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.5 m -56.18 114.35 7.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.988 -0.551 . . . . 1.46 111.055 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.58 142.51 9.75 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.293 1.995 . . . . 0.94 112.214 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -163.14 152.1 14.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.435 -0.348 . . . . 1.69 111.166 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.5 ' CZ3' HG23 ' A' ' 109' ' ' VAL . 1.7 m95 -106.12 125.99 51.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.32 109.967 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.471 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 36.2 m-85 -85.94 138.8 31.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.114 -0.235 . . . . 1.03 110.641 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.61 144.44 54.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.193 0.52 . . . . 0.24 111.766 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.864 ' CE2' HD21 ' A' ' 91' ' ' LEU . 83.1 t80 -132.65 88.61 2.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.469 -0.787 . . . . 0.99 109.983 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' CG ' ' HB3' ' A' ' 56' ' ' SER . 9.5 p90 -53.22 158.13 1.69 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.97 0.414 . . . . 1.57 110.888 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.864 HD21 ' CE2' ' A' ' 89' ' ' TYR . 21.6 mt -160.05 146.38 15.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.878 -0.601 . . . . 0.45 110.982 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.91 -94.11 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.647 -0.706 . . . . 1.6 112.287 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.412 ' HA ' ' CB ' ' A' ' 97' ' ' ALA . 3.1 p -149.07 -54.09 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.682 0.277 . . . . 0.72 111.383 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -49.35 -57.94 8.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.497 -0.859 . . . . 0.79 112.374 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -60.98 -149.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.865 2.376 . . . . 1.71 111.703 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.89 -64.63 0.66 Allowed 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.687 0.28 . . . . 2.45 110.943 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 93' ' ' THR . . . 47.08 29.02 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.87 111.254 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 t -98.12 -39.82 8.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 1.51 110.949 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.723 HD23 ' HZ2' ' A' ' 110' ' ' TRP . 7.8 mp -47.6 166.41 0.2 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 1.12 110.626 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.826 ' CG ' ' HB2' ' A' ' 103' ' ' ALA . 73.8 Cg_endo -75.63 3.49 5.89 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.661 2.241 . . . . 0.65 113.682 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.504 ' CD1' HD12 ' A' ' 62' ' ' ILE . 17.5 t80 61.61 74.25 0.45 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.029 0.443 . . . . 1.09 110.551 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 110' ' ' TRP . . . 116.28 25.64 3.44 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.82 -0.627 . . . . 0.48 112.607 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.826 ' HB2' ' CG ' ' A' ' 100' ' ' PRO . . . -64.66 80.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.399 . . . . 1.45 111.059 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -48.39 138.76 9.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 2.15 110.936 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.54 -173.16 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 2.35 110.932 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -78.28 -64.51 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 2.66 110.891 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.45 27.97 15.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.47 112.524 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.423 HG23 ' CD1' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -127.47 131.27 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.57 111.065 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.736 HG21 ' O ' ' A' ' 42' ' ' LEU . 47.2 t -115.9 109.42 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.41 111.135 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.723 ' HZ2' HD23 ' A' ' 99' ' ' LEU . 57.5 m95 -84.99 151.52 24.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.011 -0.54 . . . . 0.45 111.547 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.491 HG11 ' HE1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -163.88 132.71 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.619 -0.719 . . . . 0.21 110.752 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB1' HG22 ' A' ' 62' ' ' ILE . . . -121.31 147.19 46.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 0.45 111.353 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.3 t -61.34 170.63 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.525 . . . . 0.54 111.04 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -68.4 70.76 0.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 2.7 111.01 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.29 82.68 1.43 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 1.54 112.614 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.52 125.7 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.789 0.328 . . . . 0.76 110.862 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.2 tp -89.44 -21.16 23.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 1.73 111.957 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 75.18 108.14 0.07 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.799 0.333 . . . . 2.57 110.895 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.7 p -145.69 158.35 49.96 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 0.84 111.279 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.55 135.02 11.44 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.917 2.412 . . . . 0.98 112.768 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.86 83.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 4.28 110.712 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.46 126.53 50.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 3.12 110.92 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.411 ' CD2' HD13 ' A' ' 124' ' ' ILE . 1.2 p-80 170.38 42.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.221 -0.445 . . . . 1.68 110.908 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.411 HD13 ' CD2' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -147.51 -177.04 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.92 111.216 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 68.01 33.57 79.49 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.775 -0.726 . . . . 1.75 111.925 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.79 77.95 1.57 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.859 0.361 . . . . 1.17 110.913 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -81.51 58.4 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 1.89 111.394 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 130' ' ' ASN . 11.7 t30 -59.59 127.1 84.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.557 -0.535 . . . . 2.42 109.557 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.08 78.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.489 2.126 . . . . 1.5 112.521 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 128' ' ' ASN . 1.9 m-20 167.45 -34.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.881 -0.6 . . . . 2.84 110.258 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.79 -70.32 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.96 -0.564 . . . . 2.75 110.882 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -175.2 160.77 2.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.277 -0.419 . . . . 2.63 111.318 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.405 ' O ' ' CZ3' ' A' ' 30' ' ' TRP . . . -61.48 -163.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.553 . . . . 2.01 110.818 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.737 ' HB1' ' N ' ' A' ' 31' ' ' PHE . . . -102.66 129.47 49.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 1.42 111.422 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 m -55.45 -23.16 23.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.52 111.986 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.801 HG12 HG23 ' A' ' 32' ' ' THR . 3.6 m 47.81 114.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.675 0.79 . . . . 0.77 112.934 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -43.18 167.67 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.354 -0.839 . . . . 0.41 112.567 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -158.11 86.27 0.89 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.226 -0.897 . . . . 1.66 110.352 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.82 HD13 ' O ' ' A' ' 143' ' ' THR . 96.3 mt -45.54 138.95 4.92 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.206 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 139' ' ' LEU . 35.5 Cg_exo -59.39 -162.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.332 2.021 . . . . 0.86 112.052 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -51.01 -53.84 29.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.974 0.416 . . . . 2.4 110.18 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.23 -123.09 2.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.866 -0.683 . . . . 1.84 111.693 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.82 ' O ' HD13 ' A' ' 139' ' ' LEU . 2.6 m 48.16 40.77 14.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.969 0.414 . . . . 0.56 110.859 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.622 ' C ' HD23 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -57.48 -164.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.829 -0.623 . . . . 1.53 111.462 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -110.15 154.89 42.58 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.324 . . . . 0.69 110.843 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.449 ' HB2' ' CE1' ' A' ' 149' ' ' PHE . 36.6 Cg_exo -59.0 -147.88 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.938 2.425 . . . . 0.62 112.551 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -46.16 -86.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.504 0.187 . . . . 2.61 111.504 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -121.68 78.43 0.33 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.687 -0.768 . . . . 1.9 111.932 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.673 ' O ' HD12 ' A' ' 145' ' ' LEU . 4.9 m-85 -117.17 154.82 30.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.881 0.372 . . . . 1.1 111.405 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.415 ' CZ ' ' HA2' ' A' ' 153' ' ' GLY . 4.5 t80 -115.41 126.46 54.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.571 . . . . 1.43 110.574 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.735 ' HB1' ' OE2' ' A' ' 152' ' ' GLU . . . -45.03 165.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.867 -0.606 . . . . 0.33 112.226 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.735 ' OE2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -35.75 -36.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.0 -1.0 . . . . 2.03 112.056 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.415 ' HA2' ' CZ ' ' A' ' 150' ' ' TYR . . . 127.83 -65.2 0.58 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.446 -0.883 . . . . 1.5 112.449 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 76.3 p 50.38 77.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.356 . . . . 1.97 110.933 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 110.52 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 6.55 110.861 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.62 90.43 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 5.02 112.51 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 120.74 105.23 2.0 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.726 -0.749 . . . . 7.45 112.481 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.208 -0.901 . . . . 9.85 110.901 -179.992 . . . . . . . . 0 0 . 1 stop_ save_